Trial Watch

Phase II and Phase III attrition rates 2011–2012

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Trends in attrition rates.

Author information

Correspondence to Philip Miller.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Arrowsmith, J., Miller, P. Phase II and Phase III attrition rates 2011–2012. Nat Rev Drug Discov 12, 569 (2013).

Download citation

Further reading